Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism

NCT06192199 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT06192199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06192199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
December 1, 2025
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pulmonary embolism